Loading clinical trials...
Loading clinical trials...
The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hisamitsu Pharmaceutical Co., Inc.
NCT07449078 · Chronic Ankle Sprain, Chronic Ankle Sprains
NCT06868316 · Ankle Sprains, Ankle Injuries and Disorders
NCT06897293 · Ankle Sprain, Hypermobility, Joint
NCT06645262 · Ankle Sprain 1St Degree
NCT06631690 · Anterior Cruciate Ligament Tear, Ankle Sprains
Hisamitsu Investigator Site
Birmingham, Alabama
Hisamitsu Investigator Site
Phoenix, Arizona
Hisamitsu Investigator Site
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions